Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Kailera Therapeutics

Biotech & Life Sciences · Waltham, United States · Founded 2024 · IPO 2026 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.67B
Market cap · Apr/2026

Investors

14 investors on Kailera Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Lyra Capital
RTW Investments
Atlas Venture
Bain Capital Life Sciences
Series B+ 10 investors entered at this stage
Qatar Investment Authority
Royalty Pharma
Invus
CPP Investments
Sirona Capital
T. Rowe Price
Perseverance Capital Management
Surveyor Capital
Bain Capital Private Equity
Janus Henderson Investors

Global footprint

Where Kailera Therapeutics has talent and traffic

Web traffic by country
12K monthly visits
across markets
🇺🇸 United States94.2%
🇮🇳 India6.7%
Top 2 markets shown

See Kailera Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo